Ribon Therapeutics (@RibonTx) / X

New directions in poly(ADP‐ribose) polymerase biology - Bock - 2016 - The FEBS Journal - Wiley Online Library

Investors – Ribon Therapeutics

Ribon Therapeutics Raises $65 Million to Advance Pipeline of Novel Therapeutics Targeting Cellular Stress Pathways for Cancer

Ribon Therapeutics on X: We will be presenting three sets of findings from both our development platform and lead program, RBN-2397, at the #AACR20 Virtual Annual Meeting II, June 22-24. Details

A Look Inside Our Culture – Ribon Therapeutics

A Look Inside Our Culture – Ribon Therapeutics

Ribon Therapeutics (@RibonTx) / X

Investors – Ribon Therapeutics

Ribon Therapeutics (@RibonTx) / X

Ribon Therapeutics (@RibonTx) / X

Home – Ribon Therapeutics

Articles about Ribon Therapeutics

News Profile

Molecules, Free Full-Text

Ribon Therapeutics - Crunchbase Company Profile & Funding